Navigation Links
Genomatix wins the 'INDUSTRIEPREIS 2012' in the biotech category at Hannover Messe
Date:4/27/2012

Munich, Germany, April 27th, 2012 - Genomatix is proud to announce that it has been awarded the "INDUSTRIEPREIS 2012" in the biotech category at Hannover Messe, the world's biggest technology trade show. The INDUSTRIEPREIS is awarded in 14 categories to companies for products of a high technological, economic, ecological or social value. Nominees and winners are chosen by a panel of 30 experts including professors and specialized journalists. Genomatix has received the INDUSTRIEPREIS for its data analysis and interpretation platform Genomatix Genome Analyzer (GGA).

"We're really proud to have received this award for a data analysis solution", says Dr. Korbinian Grote, product manager at Genomatix. "Usually the focus on big technology fairs is more on lab equipment providers, in our field the sequencer manufacturers stand out with ever new records of gigabases of DNA data they can produce. But researchers also need solutions to analyze and interpret these data to extract the information from it and generate new biomedical knowledge." "Being appreciated for our data analysis solutions is certainly a big motivation for the whole team to come up with even more innovative ideas on how to deal with the increasing deluge of Next Generation Sequencing data", adds Dr. Martin Seifert, CEO of Genomatix, "getting an award that explicitly rewards products of technological and social value underlines that NGS is quickly moving from a research tool into the broader field of clinical application."


'/>"/>
Contact: Korbinian Grote
grote@genomatix.de
0049-599-7660
Genomatix Software GmbH
Source:Eurekalert  

Page: 1

Related biology news :

1. Genomatix to partner in $41 million European epigenomics consortium
2. Genomatix wins "Most Creative Visualization" award at iDEA Challenge 2011
3. Genomatix, USU and HJF execute a CRADA: Prostate cancer prognostic marker discovery by NGS
4. Eurofins MWG Operon and Genomatix developed most complete human exome array
5. Eurofins MWG Operon and Genomatix launch strategic alliance
6. Genomatix gives a hand in the analysis of Wayne States sequencing projects
7. University of Michigan installs second Genomatix Genome Analyzer
8. MCTP bought Genomatix NextGen Sequencing analysis stations
9. Genomatix gets patent for comparative genomics method
10. CRG buys Genomatix Next Generation Sequencing analysis solution
11. Boehringer Ingelheim uses Genomatix Next Generation Sequencing data analysis systems
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genomatix wins the 'INDUSTRIEPREIS 2012' in the biotech category at Hannover Messe
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... 23, 2016 , ... Supplyframe, the Industry Network for electronics ... Lab . Located in Pasadena, Calif., the Design Lab’s mission is to bring ... designed, built and brought to market. , The Design Lab is Supplyframe’s physical ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the ... the Dow Jones Industrial Average edged 0.27% lower to finish ... 0.17%. Stock-Callers.com has initiated coverage on the following equities: Infinity ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... ). Learn more about these stocks by accessing their free ...
Breaking Biology Technology: